Overview

Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
After successful screening, first the investigators first treat patients of severe alcoholic hepatitis with steroids for 7 days. Patients who are found to be unresponsive as per Lille's score [>0.45] would be randomized into either placebo group or G-CSF group. Responders to steroids will continue on steroids for 28 days followed by 2 weeks of tapering. Non responders will be randomized to receive G-CSF for 28days.
Phase:
N/A
Details
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Treatments:
Lenograstim